Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

NCT01257308 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-12-09

No results posted yet for this study

Summary

We wants to analyse the EML4-ALK mutation rate in the patients who have non-small cell lung cancer.

Conditions

  • Lung Cancer Patients

Sponsors & Collaborators

  • Taipei Medical University WanFang Hospital

    lead OTHER

Principal Investigators

  • Hsin-Gjin Eugene Liu · Taipei Medical University WanFang Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Completion
2013-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257308 on ClinicalTrials.gov